USANA Health Sciences, Inc.
USNA
$23.83
$0.090.38%
NYSE
| 12/28/2024 | 09/28/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 6.69% | -5.94% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 6.69% | -5.94% | |||
| Cost of Revenue | -1.79% | -2.67% | |||
| Gross Profit | 8.76% | -6.71% | |||
| SG&A Expenses | 14.78% | -6.03% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 11.26% | -5.34% | |||
| Operating Income | -47.38% | -12.55% | |||
| Income Before Tax | -43.95% | -7.89% | |||
| Income Tax Expenses | -25.70% | -18.11% | |||
| Earnings from Continuing Operations | -57.73% | 1.68% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -58.01% | 1.68% | |||
| EBIT | -47.38% | -12.55% | |||
| EBITDA | -36.31% | -11.47% | |||
| EPS Basic | -58.08% | 1.65% | |||
| Normalized Basic EPS | -44.29% | -7.92% | |||
| EPS Diluted | -58.87% | 2.96% | |||
| Normalized Diluted EPS | -44.27% | -7.54% | |||
| Average Basic Shares Outstanding | 0.14% | 0.03% | |||
| Average Diluted Shares Outstanding | 0.11% | -0.40% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||